ClearArc Capital’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$455K Sell
1,409
-657
-32% -$199K 0.18% 148
2019
Q3
$611K Buy
2,066
+10
+0.5% +$2.95K 0.18% 144
2019
Q2
$736K Sell
2,056
-281
-12% -$88.7K 0.22% 111
2019
Q1
$706K Sell
2,337
-59
-2% -$17.2K 0.19% 124
2018
Q4
$699K Sell
2,396
-1,068
-31% -$331K 0.21% 116
2018
Q3
$1.24M Buy
3,464
+23
+0.7% +$7.37K 0.16% 138
2018
Q2
$935K Sell
3,441
-12
-0.3% -$3.05K 0.13% 165
2018
Q1
$794K Buy
3,453
+67
+2% +$15.4K 0.12% 188
2017
Q4
$720K Sell
3,386
-1
-0% -$206 0.1% 206
2017
Q3
$656K Sell
3,387
-8
-0.2% -$1.49K 0.1% 211
2017
Q2
$573K Sell
3,395
-24
-0.7% -$4.15K 0.09% 233
2017
Q1
$568K Buy
3,419
+45
+1% +$7.09K 0.09% 231
2016
Q4
$420K Sell
3,374
-46
-1% -$6.2K 0.08% 271
2016
Q3
$604K Sell
3,420
-21
-0.6% -$3.36K 0.11% 202
2016
Q2
$470K Buy
3,441
+3
+0.1% +$426 0.09% 245
2016
Q1
$542K Buy
3,438
+24
+0.7% +$3.67K 0.11% 211
2015
Q4
$637K Buy
+3,414
New +$551K 0.13% 188

Other funds holding ILMN

ClearArc Capital's ILMN Position: Q4 2019 in Review

ClearArc Capital reduced its Illumina (ILMN) stake by 32% in Q4 2019, selling an estimated $199K and leaving 1,409 shares worth $455K. The position accounts for 0.18% of the portfolio, ranked #148.

ClearArc Capital first reported a position in ILMN in Q4 2015 and has held it in 17 quarters since. The position peaked at $1.24M in Q3 2018. 890 funds tracked by Wall St. Rank hold ILMN as of Q4 2019.

  • ClearArc Capital held 1,409 shares of Illumina worth $455K as of Q4 2019.
  • ClearArc Capital sold 657 Illumina shares in Q4 2019, an estimated $199K.
  • Illumina made up 0.18% of ClearArc Capital's portfolio in Q4 2019, its #148 holding.
  • ClearArc Capital first reported a position in Illumina in Q4 2015 and has held it in 17 quarters since.
  • ClearArc Capital's Illumina position peaked at $1.24M in Q3 2018.
  • 890 funds tracked by Wall St. Rank held Illumina as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.